These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9732885)

  • 21. Atrial fibrillation ablation leads to long-term improvement of quality of life and reduced utilization of healthcare resources.
    Goldberg A; Menen M; Mickelsen S; MacIndoe C; Binder M; Nawman R; West G; Kusumoto FM
    J Interv Card Electrophysiol; 2003 Feb; 8(1):59-64. PubMed ID: 12652179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy and safety of three-dimensional electroanatomical mapping system for catheter ablation of paroxysmal supraventricular tachycardia in children].
    Chen XJ; Chen YW; Dong JZ; Qiu CG; Tao HL; Han ZY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Aug; 46(8):617-621. PubMed ID: 30139012
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias.
    Bubien RS; Knotts-Dolson SM; Plumb VJ; Kay GN
    Circulation; 1996 Oct; 94(7):1585-91. PubMed ID: 8840848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is an individualized treatment possible in patients with paroxysmal supraventricular reentrant tachycardia?
    Alboni P; Gianfranchi L; Fucà G
    Ital Heart J; 2002 Dec; 3(12):738-42. PubMed ID: 12611126
    [No Abstract]   [Full Text] [Related]  

  • 25. Underuse of Catheter Ablation as First-Line Therapy for Supraventricular Tachycardia.
    Hollanda Oliveira L; Viana MDS; Luize CM; de Carvalho RS; Cirenza C; de Oliveira Dietrich C; Correia LC; das Virgens C; Medeiros Filgueiras J; Barreto M; Porto E; Coutinho E; de Paola Â
    J Am Heart Assoc; 2022 Jun; 11(11):e022648. PubMed ID: 35656985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health care utilization among adenosine-sensitive supraventricular tachycardia patients presenting to the emergency department.
    Dewland TA; Oesterle A; Stein J; Marcus GM
    J Interv Card Electrophysiol; 2017 Aug; 49(2):103-109. PubMed ID: 28600671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of advancing age on clinical presentation, treatment efficacy and safety, and long-term outcome of inducible paroxysmal supraventricular tachycardia without pre-excitation syndromes: A cohort study of 1960 patients included over 25 years.
    Brembilla-Perrot B; Sellal JM; Olivier A; Villemin T; Beurrier D; Vincent J; Manenti V; de Chillou C; Bozec E; Girerd N
    PLoS One; 2018; 13(1):e0187895. PubMed ID: 29304037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Healthcare Resource Use and Expenditures in Patients Newly Diagnosed With Paroxysmal Supraventricular Tachycardia.
    Sacks NC; Cyr PL; Preib MT; Everson K; Wood DR; Raza S; Pokorney SD
    Am J Cardiol; 2020 Jan; 125(2):215-221. PubMed ID: 31771758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiofrequency catheter ablation and antiarrhythmic drug therapy: a prospective, randomized, 4-year follow-up trial: the APAF study.
    Pappone C; Vicedomini G; Augello G; Manguso F; Saviano M; Baldi M; Petretta A; Giannelli L; Calovic Z; Guluta V; Tavazzi L; Santinelli V
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):808-14. PubMed ID: 21946315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Improvement of mental health and the quality of life after catheter ablation for paroxysmal supraventricular tachycardia].
    Fukuta Y; Fukuta M; Hayashi E; Iwa T; Ito T; Tanaka T; Nakagawa T
    Nihon Koshu Eisei Zasshi; 2004 Aug; 51(8):592-602. PubMed ID: 15481546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follow-up of children or teenagers with paroxysmal supraventricular tachycardia, but without pre-excitation syndrome.
    Brembilla-Perrot B; Olivier A; Villemin T; Manenti V; Vincent J; Moulin-Zinsch A; Lethor JP; Tisserant A; Marçon F; Jean Marc S
    Arch Cardiovasc Dis; 2017 Nov; 110(11):599-606. PubMed ID: 28751003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Financial audit of antitachycardia pacing for the control of recurrent supraventricular tachycardia.
    Griffith MJ; Bexton RS; McComb JM
    Br Heart J; 1993 Mar; 69(3):272-5. PubMed ID: 8461232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender-related differences in outcomes and resource utilization in patients undergoing radiofrequency ablation of supraventricular tachycardia: results from Patients' Perspective on Radiofrequency Catheter Ablation of AVRT and AVNRT Study.
    Farkowski MM; Pytkowski M; Maciag A; Golicki D; Wood KA; Kowalik I; Kuteszko R; Szwed H
    Europace; 2014 Dec; 16(12):1821-7. PubMed ID: 24919538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Radiofrequency Ablation and Antiarrhythmic Medications on the Quality of Life of Patients with Supraventricular Tachycardias: Preliminary Validation of the Greek Version of the Umea22 (U22) Questionnaire.
    Domeyer PR; Giannakidou SC; Kyriakou P; Katsari V; Antoniadis AP; Lagos IK; Fragakis N; Varaklioti A; Vassilikos VP
    Biomed Res Int; 2018; 2018():3059478. PubMed ID: 30402470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of medical care costs between successful radiofrequency catheter ablation and surgical ablation of accessory pathways in the pediatric age group.
    Case CL; Gillette PC; Crawford FA; Knick BJ
    Am J Cardiol; 1994 Mar; 73(8):600-1. PubMed ID: 8147308
    [No Abstract]   [Full Text] [Related]  

  • 36. Cost effectiveness of day stay versus inpatient radiofrequency (RF) ablation for the treatment of supraventricular tachyarrhythmias.
    Weerasooriya HR; Harris AH; Davis MJ
    Aust N Z J Med; 1996 Apr; 26(2):206-9. PubMed ID: 8744619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AV nodal reentrant tachycardia or AV reentrant tachycardia using a concealed bypass tract-related adverse events.
    Brembilla-Perrot B; Bénichou M; Brembilla A; Bozec E; Dorlet S; Sellal JM; Olivier A; Manenti V; Villemin T; Beurrier D; Moulin-Zinsch A; De Chillou C; Girerd N
    Int J Cardiol; 2015 Nov; 199():84-9. PubMed ID: 26188825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial.
    Walfridsson H; Walfridsson U; Nielsen JC; Johannessen A; Raatikainen P; Janzon M; Levin LA; Aronsson M; Hindricks G; Kongstad O; Pehrson S; Englund A; Hartikainen J; Mortensen LS; Hansen PS
    Europace; 2015 Feb; 17(2):215-21. PubMed ID: 25567068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiofrequency catheter ablation as primary therapy for supraventricular tachycardia.
    Goldner B; Jadonath R; Merkatz K; Cohen TJ
    J Invasive Cardiol; 1995 May; 7(4):107-12; discussion 113-4. PubMed ID: 10158106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catheter ablation in supraventricular tachycardia.
    Deshpande S; Jazayeri M; Dhala A; Blanck Z; Sra J; Bremner S; Akhtar M
    Annu Rev Med; 1995; 46():413-30. PubMed ID: 7598475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.